YZi Labs Exposes 10X Capital’s Hidden 10% Stake in BNB Treasury Giant CEA Industries
- What’s the Core Allegation Against 10X Capital?
- How Did a Cannabis Company Become a BNB Powerhouse?
- Why Are Poison Pills and Secret Deals Fueling the Fire?
- What’s Next for This High-Stakes Corporate Battle?
- FAQs: The CEA Industries Controversy Explained
YZi Labs has dropped a bombshell allegation that 10X Capital and its affiliates secretly control over 10% of CEA Industries' shares—far beyond the 5% SEC disclosure threshold. The dispute centers on undisclosed warrants, shadowy board influence, and a soured $500M PIPE deal from 2025 that transformed this former cannabis company into a BNB-focused treasury behemoth. With poison pills flying and accusations of secret fee agreements, this corporate battle offers more drama than a Netflix financial thriller.
What’s the Core Allegation Against 10X Capital?
According to recently surfaced evidence, YZi Labs claims 10X Capital and related parties now hold 2,376,236 shares of CEA Industries (ticker: BNC)—equivalent to >10% of outstanding stock. The kicker? These shares allegedly stem from warrants that weren’t properly disclosed in SEC filings. "This isn’t just paperwork—it’s a fundamental breach of shareholder transparency," stated a YZi Labs spokesperson. Under SEC Rule 13D, any entity crossing the 5% ownership threshold must file detailed disclosures within 10 days. 10X Capital’s silence, YZi argues, suggests coordinated "shadow group" tactics to entrench the current board.
How Did a Cannabis Company Become a BNB Powerhouse?
CEA Industries pulled off one of 2025’s most radical pivots: abandoning cannabis to become the world’s largest publicly traded BNB treasury. The shift was bankrolled by a $500M August 2025 PIPE deal led by 10X Capital, with YZi Labs as a key backer. "We envisioned BNC as the institutional gateway for U.S. investors to access BNB’s ecosystem," explained 10X’s managing partner during a now-infamous November 2025 conference. But trouble emerged when CEO David Namdar hinted at diversifying into Solana—a MOVE YZi called "strategic betrayal" in their December 2025 termination notice.
Why Are Poison Pills and Secret Deals Fueling the Fire?
The board retaliated with classic defensive maneuvers: a shareholder rights plan (a.k.a. "poison pill") and bylaw amendments making director nominations harder. YZi Labs fired back, alleging these measures "protect incompetence, not investors." Meanwhile, BNC directors accused YZi of a shady 2025 side deal to skim asset management fees—an agreement YZi claims it voluntarily canceled that December. "This is PR mudslinging to distract from their failed BNB treasury management," countered YZi’s legal team.
What’s Next for This High-Stakes Corporate Battle?
With YZi pushing for board seats and 10X’s undisclosed stake looming, regulators may soon intervene. Historical data from TradingView shows BNC’s stock volatility spiked 47% during similar governance fights in Q4 2025. "Institutional investors hate uncertainty," noted a BTCC market analyst. "If this escalates, we could see forced disclosures, SEC scrutiny, or even activist investor involvement." One thing’s clear: in the wild west of crypto treasuries, transparency remains the rarest asset of all.
FAQs: The CEA Industries Controversy Explained
What percentage of BNC does 10X Capital actually own?
YZi Labs alleges 10X Capital and affiliates control 2,376,236 shares (~10.2%), though no Schedule 13D has been filed to confirm this.
Why does the 5% ownership threshold matter?
SEC rules require detailed disclosures at 5%+ to prevent covert takeovers. Violations can trigger fines or trading suspensions.
How did CEA Industries pivot from cannabis to BNB?
The August 2025 $500M PIPE deal—backed by heavyweights like YZi Labs—rebranded BNC as a BNB treasury play, though solana rumors later caused infighting.
